PMV Pharma appoints Dr. Carol Gallagher to board, replacing Thilo Schroeder

PMV Pharmaceuticals, Inc.

Thilo Schroeder resigned from board effective Nov 3, 2022; resignation not related to any disagreement.
Carol Gallagher, Pharm.D., appointed as Class I director effective Nov 3, 2022.
Gallagher has over 30 years biotech leadership and currently serves as venture partner at NEA.
She joins PMV as the company notes recent clinical proof of concept for lead candidate PC14586.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Carol Gallagher

Director

PMVP · PMV Pharmaceuticals, Inc.

Effective: 2022-11-03
Filed: November 4, 2022, 7:59 PM ET

On November 3, 2022, upon the recommendation of its Nominating and Corporate Governance Committee, the Board of the Company unanimously approved the appointment of Carol Gallagher, Pharm.D. as a Class I director of the Company to fill the vacancy of Dr. Schroeder’s seat on the Board of the Company.

Departed

Thilo Schroeder

Director

PMVP · PMV Pharmaceuticals, Inc.

Effective: 2022-11-03
Successor: Carol Gallagher
Filed: November 4, 2022, 7:59 PM ET

On November 3, 2022, Thilo Schroeder, Ph.D., notified PMV Pharmaceuticals, Inc. (the “Company”) of his decision to resign as a member of the Board of Directors (the “Board”), which resignation was effective on that date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Carol Gallagher was appointed as Director at PMV Pharmaceuticals, Inc..

Action: appointed
Role: Director

Exact text from the filing

On November 3, 2022, upon the recommendation of its Nominating and Corporate Governance Committee, the Board of the Company unanimously approved the appointment of Carol Gallagher, Pharm.D. as a Class I director of the Company to fill the vacancy of Dr. Schroeder’s seat on the Board of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Thilo Schroeder resigned as Director at PMV Pharmaceuticals, Inc..

Action: resigned
Role: Director

Exact text from the filing

On November 3, 2022, Thilo Schroeder, Ph.D., notified PMV Pharmaceuticals, Inc. (the “Company”) of his decision to resign as a member of the Board of Directors (the “Board”), which resignation was effective on that date.

View on SEC.gov

PMV Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-277423

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.